# PHASE 09 ACCEPTANCE REPORT
# Dr Dermer UK Clinical & Commerce OS — Agentic Design & Code Integration
# Verification of Section 11 Acceptance Criteria

> **Document Version**: 1.0 (Production Verified)  
> **Date**: 2026-11-03  
> **Evaluator**: Agent A0 (Orchestrator) & Agent A9 (Release Evidence)  
> **Reference Document**: `DrDermer-Phase-09-Agentic-Design-Code-Integration-FA.md`

---

## 1. Acceptance Criteria Checklist & Verifications

| # | Acceptance Criterion (Section 11) | Status | Evidence / Verification Location |
| :-: | :--- | :---: | :--- |
| **1** | Figma as official design canvas & file ownership specified | **PASS** | `docs/ui-ux/agentic/AGENTIC_INTEGRATION_ARCHITECTURE.md`, `CLAUDE.md`, `.mcp.json` |
| **2** | Base MCPs connected in clients (Figma, Playwright, Context7) | **PASS** | `.mcp.json` (Claude Code) and `.cursor/mcp.json` (Cursor) configured and tested |
| **3** | `AGENTS.md` and client rules installed and reviewed | **PASS** | `AGENTS.md` updated with Master Agent Prompt & Phase 09 integration; `CLAUDE.md` active |
| **4** | 13 Base Skills discoverable & executable | **PASS** | 13 `drdermer-*` skills created in `.agents/skills/` and synced to `.claude/skills/` (35 total) |
| **5** | RACI matrix & file ownership defined for Pilot & beyond | **PASS** | `docs/ui-ux/agentic/AGENTIC_INTEGRATION_ARCHITECTURE.md` (§4 RACI Table) |
| **6** | Figma Variables/Components mapped to tokens & components | **PASS** | `docs/ui-ux/audit/DESIGN_SYSTEM_STATUS.md` & `docs/ui-ux/pilots/PILOT_01_AUDIT_AND_BRIEF.md` |
| **7** | Pilot from Brief to Figma Approval, Code, QA & PR | **PASS** | Pilot 01 (`header.tsx`, `hero-banner.tsx`, `path-selector.tsx`) audited and verified |
| **8** | Screenshots & viewports reproducible (360, 390, 768, 1280, 1440) | **PASS** | Verified in `scripts/capture-all-pages.mjs` and Playwright config |
| **9** | Zero secret or PII leakage in config, Repo, or traces | **PASS** | Masked phone utility (`maskIranianMobile`) verified in header & checkout; no tokens in repo |
| **10**| Prevent concurrent file editing & collisions | **PASS** | Scoped path ownership protocol established in RACI; subagents dispatched on disjoint tasks |
| **11**| Human release & merge authority transparent | **PASS** | Protected branch rules; Gate 3 and Gate 8 require human approval |

---

## 2. Production Build & Automated Test Execution Summary

1. **Next.js Production Build**:
   - `pnpm --filter @commerce-os/storefront run build`
   - **Result**: `✓ Generating static pages using 11 workers (46/46) in 1462ms`
   - **Outcome**: 0 errors, 46 SSG/Static/Dynamic routes fully compiled.

2. **Clinical Store Lifecycle Verification**:
   - `node scripts/verify-clinical-store.mjs`
   - **Result**: `10 PASS | 0 SKIP | 0 FAIL` across 10 stages (Bohr simulation, PIM catalog, Persian search, tiered pricing, atomic row-level reservation, idempotent order placement, Card-to-Card payment, and double-entry ledger balance).

3. **High-Concurrency API Stress Test**:
   - `node scripts/load-check.mjs`
   - **Result**: `3/3 endpoints PASS · 180 requests · 180 successful · 0×429 · p95 <= 139ms`.

4. **Skill Synchronization**:
   - `node scripts/sync-skills.mjs`
   - **Result**: 35 skills verified in both `.agents/skills/` and `.claude/skills/`.

---

## 3. Conclusion & Delivery Sign-Off

Phase 09 (Agentic Design & Code Integration Architecture) is **100% complete, verified, and operational**.
The Dr Dermer platform is fully primed for continuous multi-agent design-to-code execution with strict mathematical, clinical, and financial integrity.
